[1]
Taqdees Zahra et al. 2024. EFFICACY AND SAFETY OF SEMAGLUTIDE IN NON-ALCOHOLIC FATTY LIVER DISEASE. Journal of Population Therapeutics and Clinical Pharmacology. 31, 8 (Aug. 2024), 772–777. DOI:https://doi.org/10.53555/jptcp.v31i8.7465.